NEW YORIK, July 26 - Applied Biosystems on Thursday reported a 3.4 percent increase in fiscal fourth quarter revenues to $405.1 million, compared with $391.8 million in the year ago quarter as a drop in instrument sales offset higher sales of consumables and services.

The company posted a 12 percent drop in revenue from the sale of instruments, including software to $191.4 million from $216.9 million in the year ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.